NC

July 11, 2017

Licensing agreement of ThioBridge™ signed with Abzena (AIM: ABZA)

[…]
June 29, 2017

Clarification on the news article by Commercial Times

[…]
June 28, 2017

Important Resolutions of AGM 2017

[…]
June 11, 2017

Supplemental information on the approved application of Phase III clinical trial of OBI-822, the novel breast cancer drug, in China, US, and the EU

[…]